Skip to main content

Regulatory Science for Engineering Intuitive, Engaging, Safe and Effective Human-Device Interaction

Project 7: Develop multimodal physiological biomarkers for mild TBI. (Jose Contreras-Vidal, UH BRAIN; Michael Caiola and Meijun Ye, FDA)
Fig. 3. Illustration of multi-modal data collection platform
Fig. 3. Illustration of multi-modal data collection platform

Background: Traumatic brain injury (TBI) presents a significant challenge in civilian and military medicine with estimates that about 80% are mild TBI. Though current neurological examinations and imaging modalities are useful for the determination of moderate and severe TBIs, they have not demonstrated sensitivity to detect mTBI. TBIs, by nature, are heterogeneous and thus may be difficult to quantify using a single method. We hypothesize that a multi-modal sensor combined with a machine learning approach will lead to increased sensitivity in mTBI detection and monitoring.

Research Plan: In this project, we use a wearable system (Fig. 3) to collect synchronized neural and physiological data, namely EEG, pupillometry, eye-tracking, EMG, and heart-rate/HRV from mTBI patients and healthy subjects in a VR environment, and apply advanced signal processing and deep learning methods to the development of multi-modal physiological biomarkers. The REU student will be involved in all aspects of the research, including informed consent, data collection and analysis, and preparation of reports (e.g., conference presentations and publications).

Prerequisites: An introductory course in neuroscience and knowledge of signal processing and machine learning are desirable.

Contact Information

REU Program Director
University of Houston
Cullen College of Engineering
N207 Engineering Building 1
4726 Calhoun Road
Houston, TX 77204-4006
Fax: 713-743-4503
Email: jlcontreras-vidal [at] uh.edu (jlcontreras-vidal[at]uh[dot]edu)

This material is based upon work supported by the National Science Foundation (NSF) award # 2349657 (REU site). Any opinions, findings, conclusions, and/or recommendations expressed in these materials are those of the author(s) and do not necessarily reflect the views of NSF or the FDA.

The University of Houston and the FDA are an Equal Opportunity/Affirmative Action institutions.
Minorities, women, veterans, and persons with disabilities are encouraged to apply.